Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

Clinical trial NCT02800811 · COMPLETED

Trial details

NCT number: NCT02800811
Sponsor: OSE Immunotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis Complication of Transplant

Start date: 2015-04-01
Primary completion: 2016-06-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.